Who has invested in Cinclus Pharma?

Fjarde AP-fonden, Trill impact are named among the investors backing Cinclus Pharma.

Cinclus Pharma Funding: $26M Raised, Series B (2022)

Cinclus Pharma funding overview

Cinclus Pharma is based in Stockholm, Sweden. Cinclus Pharma has raised $26M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in April 2022. The round record for Cinclus Pharma runs through 2022; nothing later has been disclosed. Investors on record include Fjarde AP-fonden, Trill impact. 2 distinct backers are named across the disclosed rounds.

Cinclus Pharma at a glance

Total raised: $26M
Latest round: Series B
Latest round date: April 2022
Headquarters: Stockholm, Sweden
Notable investors: Fjarde AP-fonden, Trill impact

Frequently asked about Cinclus Pharma funding

How much has Cinclus Pharma raised?: Cinclus Pharma has raised $26M in total disclosed funding across the rounds on record.
Who has invested in Cinclus Pharma?: Fjarde AP-fonden, Trill impact are named among the investors backing Cinclus Pharma.
What was the latest Cinclus Pharma funding round?: The most recent disclosed round is a Series B, announced in April 2022.
Where is Cinclus Pharma based?: Cinclus Pharma is based in Stockholm, Sweden.
When did Cinclus Pharma last raise?: The last disclosed Cinclus Pharma round closed in April 2022 at Series B.

Every Cinclus Pharma figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Stockholm at a similar stage.

Cinclus Pharma Funding: $26M Raised, Series B (2022)

Cinclus Pharma funding overview

Cinclus Pharma at a glance

Frequently asked about Cinclus Pharma funding

Companies related to Cinclus Pharma (18)

Browse related funding lists (3)